← Return to 72 hours out from robotic prostate surgery ..

Discussion
sicescu2 avatar

72 hours out from robotic prostate surgery ..

Prostate Cancer | Last Active: Jun 22 11:40am | Replies (32)
Comment receiving replies
Profile picture for jeff Marchi @jeffmarc

From NCCN Guidelines Version 1.2025

For unfavorable intermediate-risk (4+3) prostate cancer treated with RT, short-term ADT (ST-ADT) (4- 6 months is recommended. Concurrent/adjuvant ADT is preferred over neoadjuvant ADT in this setting.

And further info from NCCN
In summary, ADT is a recommended treatment option for unfavorable intermediate-risk Gleason 7 prostate cancer, usually in combination with radiation therapy. However, treatment decisions should always be made through shared decision-making with a healthcare provider, taking into account individual patient factors and the specifics of the cancer.

Jump to this post

Replies to "From NCCN Guidelines Version 1.2025 For unfavorable intermediate-risk (4+3) prostate cancer treated with RT, short-term ADT..."
surftohealth88 | @surftohealth88 | Jun 20 7:29pm

Thanks so much Jeff 🙂
It seems that I misunderstood your sentence " I can’t tell you how many times people have surgery and it comes back quickly because they didn’t have ADT." Since you mentioned surgery in that sentence I thought that there is perhaps a new recommendation for people who are undergoing surgery (RP) and that they need to be on ADT also if they have 4+3.
Thanks for clarifying < 3

VIEW AND REPLY